In addition, Tang et al. proposed a biosensor for detecting four distinct lung cancer biomarkers, namely AFP, CEA, CA125, and CA15-3, with a LOD of <0.5 g/L from susceptible patients’ blood or urine. This evidence concerns the gene CEACAM5 and lung carcinoma.